Eli Lilly says it will raise drug prices in Europe to ‘make them lower’ in U.S.
By Elaine Chen and Daniel Payne
Adobe
The announcement is among the first moves by a major drugmaker to raise prices abroad in order to lower them in the U.S., in line with President Trump’s agenda. But the impact on patients in U.S. and overseas remains unclear.
By Theresa Gaffney
By Jonathan Wosen and Allison DeAngelis
By John Wilkerson
By Mike Damiano — Boston Globe
%20MH%20Testing/Larger%20Header%20Logos/STAT_Main2.png?height=88&upscale=true&name=STAT_Main2.png){kind=small}
%20MH%20Testing/Footer%20Icons/Flipboard-logo.png?width=60&height=60&upscale=true&name=Flipboard-logo.png){kind=logo}
%20MH%20Testing/Footer%20Icons/X-logo.png?width=60&height=60&upscale=true&name=X-logo.png){kind=logo}
%20MH%20Testing/Footer%20Icons/Linkedin-logo.png?width=60&height=60&upscale=true&name=Linkedin-logo.png){kind=logo}
%20MH%20Testing/Footer%20Icons/Facebook-logo.png?width=60&height=60&upscale=true&name=Facebook-logo.png){kind=logo}
%20MH%20Testing/Footer%20Icons/Youtube-logo.png?width=60&height=60&upscale=true&name=Youtube-logo.png){kind=logo}
%20MH%20Testing/Footer%20Icons/Instagram-logo.png?width=60&height=60&upscale=true&name=Instagram-logo.png){kind=logo}
%20MH%20Testing/Footer%20Icons/Threads-logo.png?width=60&height=60&upscale=true&name=Threads-logo.png){kind=logo}